Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes

NCT ID: NCT02282397


Title
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes
Purpose
Evaluate if addition and use of real time continuous glucose monitoring (RT-CGM) improves glycemic outcome of patients using multiple daily injections (MDI) and self monitoring blood glucose (SMBG) testing, who are not at target glycemic control.
Details
Additional assessments will be made to evaluate the incremental benefits of changing the insulin delivery method from MDI to CSII in patients already using CGM. Cost effectiveness and quality of life will be measured between the two groups in each phase.
Conditions
Diabetes Mellitus
Keywords
Diabetes Mellitus
Source
DexCom, Inc.
Sponsors
DexCom, Inc., Jaeb Center for Health Research
Status
Active, not recruiting
Acronym
DIaMonD
Last Updated
31 Jul 2016
URL
Official Link
Locations
Canada, United States